title: Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors.
abstract: Although the mouse spleen dendritic cell (DC) is perhaps the most intensively studied DC type, little has been published concerning its human equivalent. In this report, rare event flow cytometry and in situ immunofluorescence were used to study the surface phenotype and distribution of HLA-DR(+) CD3(-)14(-)16(-)19(-) human spleen DC. Spleens from organ donors with different clinical histories were used. Most (81% +/- 9%; n = 14) spleen DCs expressed high levels of the integrin CD11c. CD11c(+) DCs were distributed in 3 distinct regions-the peri-arteriolar T-cell zones, the B-cell zones, and the marginal zone, where they formed a ring of cells surrounding the white pulp, just inside a ring of CD14(+) red pulp macrophages, apparently more regularly organized than the previously described marginating DC population in the mouse spleen. The T-cell zones contained CD86(+) DCs, among which a subpopulation expressed CD83. These mature/activated CD86(+) DCs represented a minority (12% +/- 8%) of total spleen DCs in most organ donors: most spleen DCs are immature. In 3 of 18 (17%) donors, however, most (54%-81%) of spleen DCs were CD86(+), suggesting that in vivo DC activation had occurred. In one donor, a radical shift in DC distribution from the marginal zone to the T-cell zones was also observed. This activation of spleen DCs in vivo was reminiscent of the effects of experimental microbial product injection in mice, and it seemed to correlate with bacterial infection or multiple trauma. (Blood. 2001;97:3470-3477)
authors.affiliation: Laboratoire d'Immunologie Cellulaire et Tissulaire URA CNRS 625, Service d'Urologie, Hôpital de La Pitié-Salpêtrière, Paris, France.
authors.forename: D
authors.initials: D
authors.lastname: McIlroy
authors.forename: C
authors.initials: C
authors.lastname: Troadec
authors.forename: F
authors.initials: F
authors.lastname: Grassi
authors.forename: A
authors.initials: A
authors.lastname: Samri
authors.forename: B
authors.initials: B
authors.lastname: Barrou
authors.forename: B
authors.initials: B
authors.lastname: Autran
authors.forename: P
authors.initials: P
authors.lastname: Debré
authors.forename: J
authors.initials: J
authors.lastname: Feuillard
authors.forename: A
authors.initials: A
authors.lastname: Hosmalin
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D051940:B7-2 Antigen; D018845:CD11 Antigens / Q000032:analysis; D017252:CD3 Complex / Q000032:analysis; D003713:Dendritic Cells / Q000166:cytology* / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D016130:Immunophenotyping; D018664:Interleukin-12 / Q000378:metabolism; D018950:Lipopolysaccharide Receptors / Q000032:analysis; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis; D008875:Middle Aged; D010641:Phenotype; D013154:Spleen / Q000166:cytology*; D014019:Tissue Donors; D000097802:CD83 Antigen
chemical_list: D015703:Antigens, CD; D051940:B7-2 Antigen; D018845:CD11 Antigens; D017252:CD3 Complex; D006684:HLA-DR Antigens; D007136:Immunoglobulins; D018664:Interleukin-12; D018950:Lipopolysaccharide Receptors; D008562:Membrane Glycoproteins; D000097802:CD83 Antigen; C497964:CD86 protein, human